Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs Seer, Inc. (SEER)

LENZ Therapeutics, Inc. and Seer, Inc. are both Biotechnology companies. LENZ Therapeutics, Inc. and Seer, Inc. are of similar size ($113.0M and $112.2M). Seer, Inc. has the higher net margin (−478.1% vs −586.7%) and the lower return on invested capital (−60.8% vs 0.00%). Across the 16 metrics below, Seer, Inc. leads on 11 and LENZ Therapeutics, Inc. on 5.

Valuation

Metric LENZ SEER Biotechnology median
P/E n/m n/m 8.50
P/S 4.78 7.88 9.71
P/B 0.47 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.85 0.64 0.64
EV/Sales (5.36) (2.87) 9.21
Earnings yield (125.08%) (60.10%) (33.15%)
Free cash flow yield (111.53%) (39.27%) (25.50%)

Profitability

Metric LENZ SEER Biotechnology median
Gross margin 93.69% 47.70% 65.16%
Operating margin (631.70%) (498.19%) 0.00%
Net margin (586.74%) (478.05%) 0.00%
Free cash flow margin (532.80%) (309.34%) 0.00%
Return on equity (59.21%) (26.45%) (56.36%)
Return on assets (55.52%) (23.47%) (48.04%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric LENZ SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 6.02%
EPS growth (last fiscal year) (21.79%) 7.91% 30.26%
Revenue growth, 5-year CAGR — 90.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.55 14.74 4.72
Net debt to EBITDA 3.22 2.63 0.96

Dividend

Metric LENZ SEER Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric LENZ SEER Biotechnology median
Market cap 112.17m 112.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack